This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 Apr;35(4):269-70.

doi: 10.1097/RLU.0b013e3181d19098.

Occult prolactinoma diagnosed by FDG PET/CT

Filip Gemmel¹, Hans Balink, James Collins, Peter Oomen

Affiliations

PMID: 20305420
DOI: 10.1097/RLU.0b013e3181d19098

Case Reports

Occult prolactinoma diagnosed by FDG PET/CT

Filip Gemmel et al. Clin Nucl Med. 2010 Apr.

. 2010 Apr;35(4):269-70.

doi: 10.1097/RLU.0b013e3181d19098.

Authors

Filip Gemmel¹, Hans Balink, James Collins, Peter Oomen

Affiliation

¹ Department of Nuclear Medicine, KCL, Section Endocrinology, Medical Center Leeuwarden, the Netherlands. f.gemmel@chello.nl

PMID: 20305420
DOI: 10.1097/RLU.0b013e3181d19098

No abstract available

PubMed Disclaimer

Similar articles

A unique presentation of appendicitis: F-18 FDG PET/CT.
Koff SG, Sterbis JR, Davison JM, Montilla-Soler JL. Koff SG, et al. Clin Nucl Med. 2006 Nov;31(11):704-6. doi: 10.1097/01.rlu.0000242723.61455.a8. Clin Nucl Med. 2006. PMID: 17053390
Prolapsed endometrial cancer: FDG PET/CT findings.
Kaneta T, Hakamatsuka T, Yamada T, Sato A, Higano S, Fukuda H, Takahashi S, Yamada S. Kaneta T, et al. Clin Nucl Med. 2006 Mar;31(3):180. doi: 10.1097/01.rlu.0000200886.11045.8b. Clin Nucl Med. 2006. PMID: 16495748 No abstract available.
FDG PET-CT findings in epiploic appendagitis.
Purandare NC, Dua S, Shah S, Gupta K, Sharma AR, Rangarajan V. Purandare NC, et al. Clin Nucl Med. 2009 Dec;34(12):906-8. doi: 10.1097/RLU.0b013e3181bed196. Clin Nucl Med. 2009. PMID: 20139829 No abstract available.
FDG-PET CT for tumor imaging.
Miller JC, Fischman AJ, Aquino SL, Blake MA, Thrall JH, Lee SI. Miller JC, et al. J Am Coll Radiol. 2007 Apr;4(4):256-9. doi: 10.1016/j.jacr.2006.10.011. J Am Coll Radiol. 2007. PMID: 17412280 Review. No abstract available.
[Positron emission tomography (PET) and PET/CT for guiding therapy in oncology].
Haug AR, Bartenstein P. Haug AR, et al. Dtsch Med Wochenschr. 2011 Mar;136(10):468-72. doi: 10.1055/s-0031-1274529. Epub 2011 Mar 1. Dtsch Med Wochenschr. 2011. PMID: 21365523 Review. German. No abstract available.

See all similar articles

Cited by

Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
Seok H, Lee EY, Choe EY, Yang WI, Kim JY, Shin DY, Cho HJ, Kim TS, Yun MJ, Lee JD, Lee EJ, Lim SK, Rhee Y. Seok H, et al. Korean J Intern Med. 2013 Jan;28(1):81-8. doi: 10.3904/kjim.2013.28.1.81. Epub 2012 Dec 28. Korean J Intern Med. 2013. PMID: 23346000 Free PMC article.
Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.
Yao A, Balchandani P, Shrivastava RK. Yao A, et al. World Neurosurg. 2017 Aug;104:489-498. doi: 10.1016/j.wneu.2017.04.128. Epub 2017 Apr 28. World Neurosurg. 2017. PMID: 28461279 Free PMC article.
Clinical use of [¹⁸F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants.
van Trigt VR, Bakker LEH, Lu H, Pelsma ICM, Verstegen MJT, van Furth WR, Pereira Arias-Bouda LM, Biermasz NR. van Trigt VR, et al. Pituitary. 2024 Oct;27(5):614-624. doi: 10.1007/s11102-024-01430-y. Epub 2024 Jul 23. Pituitary. 2024. PMID: 39042164 Free PMC article.
A Rationale for the Use of F18-FDG PET/CT in Fever and Inflammation of Unknown Origin.
Balink H, Verberne HJ, Bennink RJ, van Eck-Smit BL. Balink H, et al. Int J Mol Imaging. 2012;2012:165080. doi: 10.1155/2012/165080. Epub 2012 Dec 17. Int J Mol Imaging. 2012. PMID: 23316356 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information